Study of dissolved radon and optimization of <sup>211</sup> Rn/ <sup>211</sup> At generator
Abstract Alpha particle therapy is gaining attention as a cancer treatment. 211 At, an α-emitting nuclide with a 7.2-h half-life, is ideal for labeled compound production and body retention. However, an accelerator is required for the nuclide production, which limits its use. To address this issue, a 211 Rn- 211 At generator was developed. This generator system utilizes 211 Rn for transport, and 211 At is produced by its decay for on-site use. This study analyzed the dissolution of Rn in solution to investigate gas-phase recovery conditions of Rn in the generator system. The dissolution of a Bi target in a nitric-hydrochloric acid mixture and subsequent neutralization has been shown to enhance the Rn recovery efficiency. In this study, the gas-phase Rn recovery rate reached 88 %, while 50 % of available At has been recovered, and further improvement can be expected in the future.
Authors
- Mariko Segawa (ORCID: https://orcid.org/0000-0003-0337-0317)
- Kohshin Washiyama (ORCID: https://orcid.org/0000-0002-9908-8756)
- I. Nishinaka (ORCID: https://orcid.org/0000-0002-6120-1645)
- Tomonori Ida (ORCID: https://orcid.org/0000-0002-5673-5263)
- Y. Shimizu (ORCID: https://orcid.org/0000-0001-5473-5684)
- Akihiko Yokoyama (ORCID: https://orcid.org/0000-0003-1950-8966)
- Masato Asai (ORCID: https://orcid.org/0000-0001-6397-373X)
- K. Tanaka
Institutions
- Kanazawa University (JP)
- Japan Atomic Energy Agency (JP)
- Fukushima Medical University (JP)
- National Institutes for Quantum Science and Technology (JP)
Publication Details
- Journal
- Radiochimica Acta
- Published
- 2025-12-19
- DOI
- https://doi.org/10.1515/ract-2025-0082
- Primary Topic
- Radiopharmaceutical Chemistry and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00